Patents Assigned to Wakunaga Phaemaceutical Co., Ltd. - Justia Patents Search

Patents Assigned to Wakunaga Phaemaceutical Co., Ltd.

CD36 mutant gene and methods for diagnosing diseases caused by abnormal lipid metabolism and diagnostic kits therefor

Patent number: 6306603

Abstract: The present invention provides CD36 mutant gene and methods and kits for diagnosing diseases caused by a lipid metabolism abnormality.

Type: Grant

Filed: January 3, 2000

Date of Patent: October 23, 2001

Assignee: Wakunaga Phaemaceutical Co., Ltd.

Inventors: Takanori Oka, Akio Yamane, Takao Tanaka